Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001894400 | SCV002125658 | uncertain significance | Bardet-Biedl syndrome | 2022-07-05 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 30 of the BBS1 protein (p.Pro30Thr). This variant is present in population databases (rs368510687, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with BBS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1359126). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002478136 | SCV002780628 | uncertain significance | Bardet-Biedl syndrome 1 | 2022-03-17 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004815673 | SCV005069232 | uncertain significance | Retinal dystrophy | 2021-01-01 | no assertion criteria provided | clinical testing |